Vhsquared

Designs and develops antibodies engineered to be stable in the gastrointestinal (GI) tract.

placeCambridge, England, United Kingdom calendar_todayFounded 2010 groups8 employees language vhsquared.com

Registered entities

Innovation

14 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 991 times.

YearFilings
20121
20165
20175
20188
20193
20206
20213
20222
20232

Investor mix

16 investors on record.

Investor typeCountShare
Venture capital425%
Private equity16%
Other / undisclosed1169%
Coming soon